Eli Lilly and Company (NYSE:LLY) is one of the best drug stocks to buy according to analysts. Eli Lilly and Company (NYSE:LLY ...
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A ...
Currently, Eli Lilly (LLY) is undoubtedly the leader in the weight loss drug market. The company’s obesity medication Zepbound is seeing rapid sales growth. Recently, Eli Lilly also launched an ...
Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect ...
It’s a good day to be the pharmaceutical giant Eli Lilly. Right now, Eli Lilly appears to be the leader in the GLP-1 race amid multiple difficult headwinds for Novo Nordisk. As of this writing, Novo ...
Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results